NC settles Medicaid fraud case against Abbott

Mon, 10/08/2012 - 10:36am
The Associated Press

North Carolina will reap almost $16 million from a national Medicaid fraud settlement involving Abbott Laboratories.

The state Attorney General's Office said Monday that's the state's portion of a $1.5 billion settlement with the company, Abbott agreed in federal court last week to settle claims over allegations that it promoted the anti-seizure drug Depakote for uses that the Food and Drug Administration hadn't approved.

Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. However, the company said it marketed the drug for unapproved uses, including treatment of schizophrenia, agitated dementia and autism.

Of the $15.8 million paid to North Carolina, about $1 million will go to support public schools. The remainder will go to support Medicaid efforts in the state.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.